This project aims to enhance enjoyment of sexual and reproductive health and rights – including reduction of child and early forced marriage – among adolescent girls and women in 480 rural communities ...

The Animal Health business delivered strong performance with a 13% sales growth. Merck & Co Inc (NYSE:MRK) has a robust late-phase pipeline with promising developments in oncology, cardiometabolic, ...

Lusaka [Zambia]/ Mumbai (Maharashtra) [India], January 4: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World Cancer Day 2025’ together with Africa’s First Ladies and ...

(Reuters) -Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until at least the middle of this year due to weak discretionary spending, a move that dented its full-year ...

Following on this success, Merck is shifting its focus toward areas of unmet medical ... US patent loss on the drug will create eventual pressure. Keytruda looks best positioned in the immuno ...

Gardasil was 13% of Merck’s sales in 2024, and roughly half of Gardasil sales tie to China. This increases reliance on Merck’s oncology drug Keytruda (46% of sales), which could face ...

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth ... of WINREVAIR and strong performance of our Animal Health business.” However, what Davis did not say ...

Merck Foundation marks World Cancer Day with African First Ladies by providing 194 scholarships of Oncology Training to African doctors from 32 countries. Merck Foundation together with Africa First ...

At a time when pharma is facing a challenge to keep pace with the advent of big data and personalised medicine, pharmaphorum is exploring how this revolution is changing the Medical Affairs function.

Beyond its strong oncology presence with Keytruda, Merck has promising assets in cardiovascular health, immunology, and vaccines. The company’s focus on expanding its presence in the PAH market with ...